Ultra-wide-field fluorescein angiography assessment of non-perfusion in patients with diabetic retinopathy treated with anti-vascular endothelial growth factor therapy

HIGHLIGHTS

  • who: Jean-Baptiste Morel et al. from the Ophthalmology Department, Paris Seine Saint Denis Hospital, Sorbonne Paris Nord University, Rue de Stalingrad, Bobigny, France have published the paper: Ultra-Wide-Field Fluorescein Angiography Assessment of Non-Perfusion in Patients with Diabetic Retinopathy Treated with Anti-Vascular Endothelial Growth Factor Therapy, in the Journal: (JOURNAL)
  • what: The aim of this study was to follow the change in retinal non-perfusion by UWF-FA in diabetic patients treated with anti-VEGF (aflibercept) injections for DME. At baseline, the median visual acuity was 70 ETDRS letters in the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?